Ting Niu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Coronavirus Disease

Top Venues

British journal of haematology

Blood cancer journal

BMC infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Li-Juan Chen
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Zhimei Lin, Yue Zhang, Xiang Liu, Hongmei Luo, Qian Li, Qianwen Gao, Xin Wang, Jingjing Wen, Linfeng Li, Yu Feng, Fangfang Wang, Jingcao Huang, Xinyu Zhai, Li Zhang, Ting Niu, Yuhuan Zheng
Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. British journal of haematology 205 (2) (2024)
Yuhui Chen, Jinjin Wang, Ting Niu
Clinical and diagnostic values of metagenomic next-generation sequencing for infection in hematology patients: a systematic review and meta-analysis. BMC infectious diseases 24 (1) (2024)
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response. British journal of haematology (2024)
Yuhui Chen, Jinjin Wang, Ting Niu
Clinical and diagnostic values of metagenomic next-generation sequencing for infection in hematology patients: a systematic review and meta-analysis. BMC infectious diseases 24 (1) (2024)
Yuhui Chen, Jinjin Wang, Ting Niu
Clinical and diagnostic values of metagenomic next-generation sequencing for infection in hematology patients: a systematic review and meta-analysis. BMC infectious diseases 24 (1) (2024)
Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Li-Juan Chen
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology (2024)
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia. British journal of haematology 204 (6) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response. British journal of haematology 205 (2) (2024)
Zhimei Lin, Yue Zhang, Xiang Liu, Hongmei Luo, Qian Li, Qianwen Gao, Xin Wang, Jingjing Wen, Linfeng Li, Yu Feng, Fangfang Wang, Jingcao Huang, Xinyu Zhai, Li Zhang, Ting Niu, Yuhuan Zheng
Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide. British journal of haematology (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, Yan Li, Yuping Gong, Bing Peng, Ting Niu
Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia. British journal of haematology (2024)
Linfeng Li, Mengrui Wu, Zhengyu Yu, Ting Niu
Nutritional Status Indices and Monoclonal Gammopathy of Undetermined Significance Risk in the Elderly Population: Findings from the National Health and Nutrition Examination Survey. Nutrients 15 (19) (2023)
Caixia Jing, Ailin Zhao, Jinjin Wang, Ting Niu
Efficacy of front-line immunochemotherapy for transplant-ineligible mantle cell lymphoma: A network meta-analysis of randomized controlled trials. Cancer medicine (2023)
Jian-Qing Mi, Wanhong Zhao, Hongmei Jing, Weijun Fu, Jianda Hu, Lijuan Chen, Yiwen Zhang, Dan Yao, Diana Chen, Jordan M Schecter, Fan Yang, Xiaochen Tian, Huabin Sun, Sen Hong Zhuang, Jimmy Ren, Xiaohu Fan, Jie Jin, Ting Niu, Sai-Juan Chen
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Jinbing Zhu, Qiuji Wu, Jinjin Wang, Ting Niu
Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia. Expert review of hematology 15 (4) (2022)
Shan Chong, Peng Zhao, Rui-Bin Huang, Hu Zhou, Jia-Ning Zhang, Ming Hou, Yi Liu, Hong-Xia Yao, Ting Niu, Jun Peng, Ming Jiang, Yan-Qiu Han, Jian-Da Hu, Ze-Ping Zhou, Lin Qiu, Lian-Sheng Zhang, Xin Wang, Hua-Quan Wang, Ru Feng, Lin-Hua Yang, Liang-Ming Ma, Shun-Qing Wang, Pei-Yan Kong, Wen-Sheng Wang, Hui-Ping Sun, Jing Sun, He-Bing Zhou, Tie-Nan Zhu, Li-Ru Wang, Jing-Yu Zhang, Qiu-Sha Huang, Hai-Xia Fu, Ye-Jun Wu, Yue-Ying Li, Qian-Fei Wang, Qian Jiang, Hao Jiang, Jin Lu, Xiao-Jun Huang, Xiao-Hui Zhang
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study. Blood advances 6 (14) (2022)
Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Li-Juan Chen
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms. Blood cancer journal 12 (3) (2022)
Peipei Yang, Ying Qu, Mengyao Wang, Bingyang Chu, Wen Chen, Yuhuan Zheng, Ting Niu, Zhiyong Qian
Pathogenesis and treatment of multiple myeloma. MedComm 3 (2) (2022)
Pu Kuang, Ting Lin, Xinchuan Chen, Yunfan Yang, Jie Ji, Tian Dong, Jie Wang, Yan Li, Ting Niu
Plerixafor as a preemptive or salvage therapy for healthy donors with poor mobilization of hematopoietic stem cells. Bone marrow transplantation 57 (11) (2022)
Jun Li, Dan Liao, Fujue Wang, Zhongwang Wang, Yueshan Li, Yu Xiong, Ting Niu
RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both in vitro and in vivo. Leukemia & lymphoma (2021)
Jing Xu, Ting Niu
Natural killer cell-based immunotherapy for acute myeloid leukemia. Journal of hematology & oncology 13 (1) (2020)